share_log

西藏药业(600211.SH):正在参与第4-5批国家组织药品集中采购协议期满品种江苏联盟接续采购申报工作

tibet rhodiola pharmaceutical holding (600211.SH): is currently participating in the application for the continuation of the fourth to fifth batch of national centralized drug procurement agreement expiration varieties by jiangsu alliance.

Gelonghui Finance ·  Nov 4, 2024 18:41

Gelonghui November 4th, Tibet Rhodiola Pharmaceutical Holding (600211.SH) stated at the performance briefing that the company is currently participating in the application work for the continued procurement of the 4th-5th batch of nationally organized pharmaceutical centralized procurement agreement-expired varieties by the jiangsu alliance. Please pay attention to the official website of the Jiangsu Provincial Medical Security Bureau for specific results.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment